Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$265M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$265M |
| 3 |
Xcel Energy
XEL
|
+$191M |
| 4 |
McDonald's
MCD
|
+$173M |
| 5 |
Microsoft
MSFT
|
+$162M |
Top Sells
| 1 |
BHI
Baker Hughes
BHI
|
+$253M |
| 2 |
Exelon
EXC
|
+$215M |
| 3 |
AbbVie
ABBV
|
+$206M |
| 4 |
American Electric Power
AEP
|
+$132M |
| 5 |
Kinder Morgan
KMI
|
+$129M |
Sector Composition
| 1 | Healthcare | 14.88% |
| 2 | Energy | 12.94% |
| 3 | Financials | 10.4% |
| 4 | Industrials | 8.78% |
| 5 | Consumer Discretionary | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Clearwater Paper
CLW
$344M
| $5.74M | 0.01% |
83,672
+22,825
| +38% | +$1.56M |
|
|
OREX
1202
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $5.73M | 0.01% |
+94,553
| New | +$5.73M |
|
1203
iShares MSCI Brazil ETF
EWZ
$5.55B
| $5.73M | 0.01% |
156,584
+113,254
| +261% | +$4.14M |
|
|
CALA
1204
DELISTED
Calithera Biosciences, Inc
CALA
| $5.72M | 0.01% |
+14,163
| New | +$5.72M |
|
|
CLC
1205
DELISTED
Clarcor
CLC
| $5.72M | 0.01% |
85,840
-141,260
| -62% | -$9.41M |
|
1206
iShares 7-10 Year Treasury Bond ETF
IEF
$36.1B
| $5.71M | 0.01% |
53,846
+33,637
| +166% | +$3.57M |
|
1207
Bristow Group
VTOL
$1.09B
| $5.7M | 0.01% |
134,796
+107,613
| +396% | +$4.55M |
|
|
USG
1208
DELISTED
Usg
USG
| $5.69M | 0.01% |
203,158
+150,066
| +283% | +$4.2M |
|
1209
Wintrust Financial
WTFC
$9.08B
| $5.68M | 0.01% |
121,370
+11,541
| +11% | +$540K |
|
|
NSTG
1210
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.67M | 0.01% |
407,131
-34,704
| -8% | -$483K |
|
1211
iShares 20+ Year Treasury Bond ETF
TLT
$49.6B
| $5.67M | 0.01% |
+45,011
| New | +$5.67M |
|
|
ARNA
1212
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.67M | 0.01% |
163,259
+161,659
| +10,104% | +$5.61M |
|
|
RNA
1213
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $5.66M | 0.01% |
301,769
-563,127
| -65% | -$10.6M |
|
1214
Minerals Technologies
MTX
$1.99B
| $5.63M | 0.01% |
+81,093
| New | +$5.63M |
|
|
ENLC
1215
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.62M | 0.01% |
158,147
+79,003
| +100% | +$2.81M |
|
1216
Lesaka Technologies
LSAK
$362M
| $5.62M | 0.01% |
492,530
-308,533
| -39% | -$3.52M |
|
|
ECYT
1217
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $5.61M | 0.01% |
891,342
+99,249
| +13% | +$624K |
|
|
XENT
1218
DELISTED
Intersect ENT, Inc
XENT
| $5.6M | 0.01% |
302,078
-43,963
| -13% | -$816K |
|
1219
EastGroup Properties
EGP
$8.9B
| $5.6M | 0.01% |
88,464
+68,947
| +353% | +$4.37M |
|
1220
Novavax
NVAX
$1.3B
| $5.6M | 0.01% |
47,237
+39,965
| +550% | +$4.74M |
|
|
NGHC
1221
DELISTED
National General Holdings Corp
NGHC
| $5.59M | 0.01% |
+300,507
| New | +$5.59M |
|
|
MPG
1222
DELISTED
Metaldyne Performance Group Inc.
MPG
| $5.58M | 0.01% |
+321,580
| New | +$5.58M |
|
|
LMNX
1223
DELISTED
Luminex Corp
LMNX
| $5.56M | 0.01% |
296,468
+95,222
| +47% | +$1.79M |
|
1224
Home BancShares
HOMB
$5.89B
| $5.56M | 0.01% |
345,624
+210,776
| +156% | +$3.39M |
|
1225
Bruker
BRKR
$4.69B
| $5.55M | 0.01% |
283,000
-330,466
| -54% | -$6.48M |
|